| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.32 | 0.07 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.052 | 0.07 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |